Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy (COMBINE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02772965
Recruitment Status : Recruiting
First Posted : May 16, 2016
Last Update Posted : April 21, 2020
Sponsor:
Collaborators:
Patient-Centered Outcomes Research Institute
ImproveCareNow (ICN)
The Leona M. and Harry B. Helmsley Charitable Trust
Children's Hospital Medical Center, Cincinnati
Grifols Diagnostics Solutions, Inc
National Institutes of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Information provided by (Responsible Party):
University of North Carolina, Chapel Hill

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 2021
Estimated Study Completion Date : December 2021